Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark C Leavitt
A Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor Produced in a Novel Protein Production System (AVI-014) in Healthy Subjects: A First-In Human, Single Dose, Controlled Study
BMC Clinical Pharmacology
Related publications
Pharmacokinetics of Glycosylated Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) in Healthy Male Volunteers
British Journal of Clinical Pharmacology
Pharmacology
Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage Hematopoietin
Science
Multidisciplinary
Philosophy of Science
History
Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy Volunteers
Turkiye Klinikleri Journal of Medical Sciences
Medicine
Low-Resolution Structure of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor
Journal of Molecular Biology
Structural Biology
Molecular Biology
Biophysics
Safety of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Healing Pediatric Severe Burns
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Neuroprotective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor in Transient Focal Ischemia of Mice
Journal of Cerebral Blood Flow and Metabolism
Neurology
Cardiovascular Medicine
Cardiology
Use of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in an Infant With Reticular Dysgenesis
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Clinical Efficacy and Safety of Tevagrastim® (XM02), a Biosimilar Recombinant Human Granulocyte Colony-Stimulating Factor
Biosimilars
